Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Oral olanzapine 2.5 mg once daily at bedtime until disease progression

Clinicians choose the appropriate standard antitumor drug therapy based on the patient's specific situation

All patients enrolled in the study were required to undergo a nutritional assessment and were provided with nutritional advice based on their condition